Merck Foundation Chief Executive Officer (CEO) together with African First Ladies mark ‘World Cancer Day 2026’ by building ...

Merck Foundation ( CEO, Dr. Rasha Kelej met H.E. Amai Dr. AUXILLIA MNANGAGWA, First Lady of the Republic of Zimbabwe and Ambass ...

By Michael Erman and Mariam Sunny Feb 3 (Reuters) - Merck & Co on Tuesday forecast 2026 sales and profits below Wall Street ...

Merck Foundation ( the philanthropic arm of Merck KGaA Germany, conducted the 12th Edition of their annual conference, “Merck ...

It’s still experimental but the pill helps rid the body of cholesterol in a way that today can be done only with injected ...

Merck & Co., Inc. (NYSE:MRK) Q4 2025 Earnings Call Transcript February 3, 2026 Merck & Co., Inc. beats earnings expectations.

Merck & Co anticipates lower sales by 2026 due to patent expirations on key medications, including the diabetes drug Januvia.

If our underlying assumptions prove inaccurate or uncertainties materialize, actual results may differ materially from those ...

Dr. Rasha Kelej, CEO of Merck Foundation and President of "More Than a Mother" Campaign, has been recognized as one of the 100 Most Influential Africans by the prestigious New African Magazine (UK).

South Korean vaccine maker SK bioscience has announced that it is advancing the development of a Zaire ebolavirus vaccine ...

Merck has surged nearly 30% since my prior bullish call, reflecting strong share price momentum. MRK fundamentals are robust, underpinned by stellar financial performance and promising regulatory ...

Jan 8 (Reuters) - Merck (MRK.N), opens new tab is in talks to buy cancer drug developer Revolution Medicines (RVMD.O), opens new tab in a $28 billion to $32 billion deal, the Financial Times reported ...